BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16763161)

  • 1. Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8.
    Kitajima K; Marchadier DH; Miller GC; Gao GP; Wilson JM; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1852-7. PubMed ID: 16763161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
    Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
    Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
    Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
    Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
    Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
    Yoshioka T; Okada T; Maeda Y; Ikeda U; Shimpo M; Nomoto T; Takeuchi K; Nonaka-Sarukawa M; Ito T; Takahashi M; Matsushita T; Mizukami H; Hanazono Y; Kume A; Ookawara S; Kawano M; Ishibashi S; Shimada K; Ozawa K
    Gene Ther; 2004 Dec; 11(24):1772-9. PubMed ID: 15496963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antiatherogenic effects of intravenous AAV8- and AAV2-mediated ApoA-IMilano gene transfer in hypercholesterolemic mice.
    Tian F; Wang L; Arias A; Yang M; Sharifi BG; Shah PK
    J Cardiovasc Pharmacol Ther; 2015 Jan; 20(1):66-75. PubMed ID: 24742767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1.
    Kitajima K; Marchadier DH; Burstein H; Rader DJ
    Atherosclerosis; 2006 May; 186(1):65-73. PubMed ID: 16099465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
    Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
    J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.
    Moscioni D; Morizono H; McCarter RJ; Stern A; Cabrera-Luque J; Hoang A; Sanmiguel J; Wu D; Bell P; Gao GP; Raper SE; Wilson JM; Batshaw ML
    Mol Ther; 2006 Jul; 14(1):25-33. PubMed ID: 16677864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer into skeletal muscle using novel AAV serotypes.
    Louboutin JP; Wang L; Wilson JM
    J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.
    Pañeda A; Vanrell L; Mauleon I; Crettaz JS; Berraondo P; Timmermans EJ; Beattie SG; Twisk J; van Deventer S; Prieto J; Fontanellas A; Rodriguez-Pena MS; Gonzalez-Aseguinolaza G
    Hum Gene Ther; 2009 Aug; 20(8):908-17. PubMed ID: 19419275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7).
    Evans V; Foster H; Graham IR; Foster K; Athanasopoulos T; Simons JP; Dickson G; Owen JS
    Hum Gene Ther; 2008 Jun; 19(6):569-78. PubMed ID: 18578629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
    Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
    Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.
    Sun B; Zhang H; Franco LM; Young SP; Schneider A; Bird A; Amalfitano A; Chen YT; Koeberl DD
    Mol Ther; 2005 Jan; 11(1):57-65. PubMed ID: 15585406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle.
    Evans VC; Graham IR; Athanasopoulos T; Galley DJ; Jackson CL; Simons JP; Dickson G; Owen JS
    Metabolism; 2011 Apr; 60(4):491-8. PubMed ID: 20580777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
    Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
    Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.
    Sun B; Zhang H; Franco LM; Brown T; Bird A; Schneider A; Koeberl DD
    Mol Ther; 2005 Jun; 11(6):889-98. PubMed ID: 15922959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice.
    Davis HR; Hoos LM; Tetzloff G; Maguire M; Zhu LJ; Graziano MP; Altmann SW
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):841-9. PubMed ID: 17218600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA.
    Rinaldi M; Catapano AL; Parrella P; Ciafrè SA; Signori E; Seripa D; Uboldi P; Antonini R; Ricci G; Farace MG; Fazio VM
    Gene Ther; 2000 Nov; 7(21):1795-801. PubMed ID: 11110410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.